Mining the dark transcriptome: Synthesizing the first potential drug molecules from long noncoding RNA

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising anti-inflammatory molecules. The team was inspired by advances in the field of messenger RNA (mRNA) and protein replacement therapies. They realized that a similar approach could be used to deliver lncRNA to the body, unlocking a potential new source of drugs.

The team’s approach is based on the idea that lncRNA can be synthesized outside the cell and then delivered to the body. This would allow for the development of new drugs that target specific lncRNA molecules. The team has already synthesized several lncRNA molecules that have shown promise in reducing inflammation in animal models.

The team’s work is still in the early stages, but it has the potential to revolutionize the way we develop drugs. If successful, this approach could lead to the development of new treatments for a wide range of diseases, including cancer, heart disease, and Alzheimer’s disease.

Tags: lncRNA, drug discovery, inflammation, University of Toronto Engineering, mRNA, protein replacement therapies, anti-inflammatory molecules

Viral sentences:
– A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell.
– The team was inspired by advances in the field of messenger RNA (mRNA) and protein replacement therapies.
– They realized that a similar approach could be used to deliver lncRNA to the body, unlocking a potential new source of drugs.
– The team has already synthesized several lncRNA molecules that have shown promise in reducing inflammation in animal models.
– If successful, this approach could lead to the development of new treatments for a wide range of diseases, including cancer, heart disease, and Alzheimer’s disease.,